These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 23776060)
1. Identification of a second Nutlin-3 responsive interaction site in the N-terminal domain of MDM2 using hydrogen/deuterium exchange mass spectrometry. Hernychova L; Man P; Verma C; Nicholson J; Sharma CA; Ruckova E; Teo JY; Ball K; Vojtesek B; Hupp TR Proteomics; 2013 Aug; 13(16):2512-25. PubMed ID: 23776060 [TBL] [Abstract][Full Text] [Related]
2. Differential binding of p53 and nutlin to MDM2 and MDMX: computational studies. Joseph TL; Madhumalar A; Brown CJ; Lane DP; Verma CS Cell Cycle; 2010 Mar; 9(6):1167-81. PubMed ID: 20190571 [TBL] [Abstract][Full Text] [Related]
3. An iTRAQ proteomics screen reveals the effects of the MDM2 binding ligand Nutlin-3 on cellular proteostasis. Nicholson J; Neelagandan K; Huart AS; Ball K; Molloy MP; Hupp T J Proteome Res; 2012 Nov; 11(11):5464-78. PubMed ID: 23039052 [TBL] [Abstract][Full Text] [Related]
4. Structure of a stapled peptide antagonist bound to nutlin-resistant Mdm2. Chee SM; Wongsantichon J; Soo Tng Q; Robinson R; Joseph TL; Verma C; Lane DP; Brown CJ; Ghadessy FJ PLoS One; 2014; 9(8):e104914. PubMed ID: 25115702 [TBL] [Abstract][Full Text] [Related]
5. On the interaction mechanisms of a p53 peptide and nutlin with the MDM2 and MDMX proteins: a Brownian dynamics study. ElSawy KM; Verma CS; Joseph TL; Lane DP; Twarock R; Caves LS Cell Cycle; 2013 Feb; 12(3):394-404. PubMed ID: 23324352 [TBL] [Abstract][Full Text] [Related]
6. The structure of an MDM2-Nutlin-3a complex solved by the use of a validated MDM2 surface-entropy reduction mutant. Anil B; Riedinger C; Endicott JA; Noble ME Acta Crystallogr D Biol Crystallogr; 2013 Aug; 69(Pt 8):1358-66. PubMed ID: 23897459 [TBL] [Abstract][Full Text] [Related]
7. A second p53 binding site in the central domain of Mdm2 is essential for p53 ubiquitination. Ma J; Martin JD; Zhang H; Auger KR; Ho TF; Kirkpatrick RB; Grooms MH; Johanson KO; Tummino PJ; Copeland RA; Lai Z Biochemistry; 2006 Aug; 45(30):9238-45. PubMed ID: 16866370 [TBL] [Abstract][Full Text] [Related]
8. The effects of phosphomimetic lid mutation on the thermostability of the N-terminal domain of MDM2. Worrall EG; Worrall L; Blackburn E; Walkinshaw M; Hupp TR J Mol Biol; 2010 May; 398(3):414-28. PubMed ID: 20303977 [TBL] [Abstract][Full Text] [Related]
9. Monitoring Ligand-Induced Protein Ordering in Drug Discovery. Grace CR; Ban D; Min J; Mayasundari A; Min L; Finch KE; Griffiths L; Bharatham N; Bashford D; Kiplin Guy R; Dyer MA; Kriwacki RW J Mol Biol; 2016 Mar; 428(6):1290-1303. PubMed ID: 26812210 [TBL] [Abstract][Full Text] [Related]
10. A function for the RING finger domain in the allosteric control of MDM2 conformation and activity. Wawrzynow B; Pettersson S; Zylicz A; Bramham J; Worrall E; Hupp TR; Ball KL J Biol Chem; 2009 Apr; 284(17):11517-30. PubMed ID: 19188367 [TBL] [Abstract][Full Text] [Related]
11. Quantitative lid dynamics of MDM2 reveals differential ligand binding modes of the p53-binding cleft. Showalter SA; Bruschweiler-Li L; Johnson E; Zhang F; Brüschweiler R J Am Chem Soc; 2008 May; 130(20):6472-8. PubMed ID: 18435534 [TBL] [Abstract][Full Text] [Related]
12. Molecular mimicry-based repositioning of nutlin-3 to anti-apoptotic Bcl-2 family proteins. Ha JH; Won EY; Shin JS; Jang M; Ryu KS; Bae KH; Park SG; Park BC; Yoon HS; Chi SW J Am Chem Soc; 2011 Feb; 133(5):1244-7. PubMed ID: 21210687 [TBL] [Abstract][Full Text] [Related]
13. Competitive binding between dynamic p53 transactivation subdomains to human MDM2 protein: implications for regulating the p53·MDM2/MDMX interaction. Shan B; Li DW; Brüschweiler-Li L; Brüschweiler R J Biol Chem; 2012 Aug; 287(36):30376-84. PubMed ID: 22807444 [TBL] [Abstract][Full Text] [Related]
14. The hydrophobically-tagged MDM2-p53 interaction inhibitor Nutlin-3a-HT is more potent against tumor cells than Nutlin-3a. Nietzold F; Rubner S; Berg T Chem Commun (Camb); 2019 Nov; 55(95):14351-14354. PubMed ID: 31720601 [TBL] [Abstract][Full Text] [Related]
15. Rearrangement of mitochondrial pyruvate dehydrogenase subunit dihydrolipoamide dehydrogenase protein-protein interactions by the MDM2 ligand nutlin-3. Way L; Faktor J; Dvorakova P; Nicholson J; Vojtesek B; Graham D; Ball KL; Hupp T Proteomics; 2016 Sep; 16(17):2327-44. PubMed ID: 27273042 [TBL] [Abstract][Full Text] [Related]
18. On the origin of the stereoselective affinity of Nutlin-3 geometrical isomers for the MDM2 protein. ElSawy KM; Verma CS; Lane DP; Caves LS Cell Cycle; 2013 Dec; 12(24):3727-35. PubMed ID: 24270847 [TBL] [Abstract][Full Text] [Related]
19. Role of Mdm2 acid domain interactions in recognition and ubiquitination of the transcription factor IRF-2. Pettersson S; Kelleher M; Pion E; Wallace M; Ball KL Biochem J; 2009 Mar; 418(3):575-85. PubMed ID: 19032150 [TBL] [Abstract][Full Text] [Related]
20. Hydrogen Bond Dynamic Propensity Studies for Protein Binding and Drug Design. Menéndez CA; Accordino SR; Gerbino DC; Appignanesi GA PLoS One; 2016; 11(10):e0165767. PubMed ID: 27792778 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]